← Leaderboards
Mark McLaughlin
Modulation Therapeutics, Inc.
$299,336
Attributed
$299,336
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,336 · 1
By mechanism
N43$299,336 · 1
Top collaborators
No co-investigators on record.
Most similar at Modulation Therapeutics, Inc.
Same institution · by research overlap
- Rikki Waterhouse$1,999,987
- Jose Gabriel Garcia$248,155
Others in their field
Top investigators on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$301,322,418
- Lawrence Corey · Fred Hutchinson Cancer Center$280,538,218
- Kiran Datta · Leidos Biomedical Research, Inc.$277,585,346
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
Advanced DiseaseAdverse EffectsAffinityAlpha-Melanocyte Stimulating HormoneAlpha ParticlesAnalogAnimalsAwarenessBehaviorBilateralBinding (Molecular Function)BiodistributionBioluminescence ImagingBloodBlood - Brain Barrier AnatomyBlood Urea NitrogenBody Weight DecreasedBolus InfusionBraf GeneCellsCohortContrast MediaCreatinineAcids